Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age
- PMID: 16459000
- DOI: 10.1016/j.vaccine.2006.01.026
Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age
Abstract
Question under study: To investigate the persistence of maternal IgG antibodies against Varicella-Zoster virus (VZV) in infants and young children.
Methods: Serum specimens of children aged 0-16 months who had been hospitalized in our institution between 1994 and 1999 were identified from our routine serum collection. Exclusion criteria were: preterm delivery (<37 gestational weeks); suspected varicella infection or presence of exanthema of unknown etiology at time of serum collection; transfusion of blood products during 6 months preceding serum collection; foreign born mother; and previous VZV immunization. Serotesting for IgG antibodies against VZV was performed by use of a commercially available ELISA kit.
Results: Two hundred and fifty three serum specimens from 240 patients were analyzed. Age distribution of patients at time of specimen collection was: 0-3 months: n=57; >3-6 months: n=47; >6-9 months: n=47; >9-12 months: n=48; >12-16 months: n=54. Seroprevalence rates for IgG antibodies against VZV in the different age groups were 90% (0-3 months), 38% (>3-6 months); 0% (>6-9 and >9-12 months); and 7% (>12-16 months).
Conclusions: Our results demonstrate high levels of passively acquired humoral immunity against varicella in Swiss infants during the first 3 months of life. Beyond the first 3 months of life IgG antibodies against VZV are lacking in the majority of patients and between 6 and 12 months of age all specimens tested were negative. Beyond the first year of life antibodies against varicella were detected in four samples, probably due to previous VZV infection. In accordance with current recommendations, VZV vaccination should ideally be administered to children 9 months of age and older, although our data indicate that successful immunization may be possible at earlier age (6 months onwards) in certain circumstances.
Similar articles
-
[Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life].Schweiz Med Wochenschr. 2000 Oct 14;130(41):1479-86. Schweiz Med Wochenschr. 2000. PMID: 11075412 German.
-
[Varicella-zoster virus seroprevalence in children between 0-15 years old].Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):69-75. Mikrobiyol Bul. 2004. PMID: 15293904 Turkish.
-
Seroprevalence of varicella-zoster virus in Polish population.Przegl Epidemiol. 2009;63(4):495-9. Przegl Epidemiol. 2009. PMID: 20120946
-
Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.J Infect Dis. 2008 Mar 1;197 Suppl 2:S147-51. doi: 10.1086/529448. J Infect Dis. 2008. PMID: 18419389 Review.
-
Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.Mol Biol Med. 1989 Oct;6(5):453-62. Mol Biol Med. 1989. PMID: 2560525 Review.
Cited by
-
Maternal varicella antibodies in children aged less than one year: Assessment of antibody decay.PLoS One. 2023 Nov 10;18(11):e0287765. doi: 10.1371/journal.pone.0287765. eCollection 2023. PLoS One. 2023. PMID: 37948389 Free PMC article.
-
Current Methods for the Detection of Antibodies of Varicella-Zoster Virus: A Review.Microorganisms. 2023 Feb 17;11(2):519. doi: 10.3390/microorganisms11020519. Microorganisms. 2023. PMID: 36838484 Free PMC article. Review.
-
Varicella pneumonia masquerading as interstitial lung disease: Non-specific interstitial pneumonitis.SAGE Open Med Case Rep. 2021 Nov 19;9:2050313X211059293. doi: 10.1177/2050313X211059293. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 34820129 Free PMC article.
-
Epidemiological and clinical characteristics and the approach to infant chickenpox in primary care.Eur J Pediatr. 2019 May;178(5):641-648. doi: 10.1007/s00431-019-03332-9. Epub 2019 Feb 14. Eur J Pediatr. 2019. PMID: 30767142
-
Varicella Pneumonia: Case Report and Review of a Potentially Lethal Complication of a Common Disease.J Investig Med High Impact Case Rep. 2018 Apr 18;6:2324709618770230. doi: 10.1177/2324709618770230. eCollection 2018 Jan-Dec. J Investig Med High Impact Case Rep. 2018. PMID: 29707592 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical